New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients.

Krivan, Gergely; Jolles, Stephen; Granados, Eduardo Lopes; Paolantonacci, Phillipe; Ouaja, Rabye; Cissé, Ousmane Alfa; Bernatowska, Ewa

Krivan, Gergely; Jolles, Stephen; Granados, Eduardo Lopes; Paolantonacci, Phillipe; Ouaja, Rabye; Cissé, Ousmane Alfa; Bernatowska, Ewa.

Afiliação

Krivan G; United St István and St Laszlo Hospital, Department of Pediatric Hematology and Stem Cell TransplantationBudapest, Hungary.
Jolles S; Immunodeficiency Centre for Wales, University Hospital of WalesCardiff, UK.
Granados EL; Hospital La Paz-IdiPAZMadrid, Spain.
Paolantonacci P; LFB Biotechnologies, Biopharmaceutical DirectionCourtaboeuf, France.
Ouaja R; LFB Biomédicaments, Immunology Therapeutic UnitCourtaboeuf, France.
Cissé OA; LFB Biomédicaments, Immunology Therapeutic UnitCourtaboeuf, France.
Bernatowska E; The Children's Memorial Health InstituteWarsaw, Poland.

Am J Clin Exp Immunol ; 6(5): 76-83, 2017.

Article em En | MEDLINE | ID: mdl-29181272

Palavras-chave

Intravenous immunoglobulin (IVIG); efficacy; immunomodulation; infection; safety; subcutaneous immunoglobulin (SCIG) primary immune deficiency (PID)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Clin Exp Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google